DRKS00006046招募中不适用
Therapy monitoring of omalizumab in children and adolescents with severe allergic asthma
niversitätsklinikum Gießen und Marburg0 个研究点目标入组 15 人开始时间: 2014年4月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6 Years 至 18 Years（—）
- 性别
- All
入选标准
- •severe allergic asthma
- •> 6 years of age
- •<18 years of age
- •informed consent of the patients and their parents
排除标准
- •no severe allergic asthma
- •< 6 years of age
- •> 18 years of age
研究者
相似试验
已完成
不适用
Clinical effects of treatment with omalizumab in patients with asthmaBronchial asthmaJPRN-UMIN000002765Atami Hospital International University of Health and Welfare40
已完成
2 期
Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe AsthmaAsthmaNCT00180011DiMango, Emily, M.D.18
已完成
3 期
Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)Hypereosinophilic SyndromeNCT04965636GlaxoSmithKline16
已完成
3 期
Efficacy and Safety of Omalizumab in Patients With Severe Persistent AsthmaAsthmaNCT00046748Novartis Pharmaceuticals484
Unknown
不适用
Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy AsthmaAsthmaAllergic RhinitisNCT00286416Scripps Clinic60